Analysis of the Global Oncology Drug Delivery Market

Analysis of the Global Oncology Drug Delivery Market

Future Impact of Emerging Technologies

RELEASE DATE
24-Feb-2015
REGION
Asia Pacific
Research Code: P874-01-00-00-00
SKU: LS00150-AP-MR_16991

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
LS00150-AP-MR_16991

$4,950.00

$3,712.50 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

The global oncology drug delivery market (or oncolytics market) was worth $91.00 billion in 2013 and has been growing at an annual rate of 5.0%. The market, which includes drug delivery systems for cancer therapy and cancer pain, is expected to generate $100.96 billion in 2015. The oral drug delivery systems segment accounted for an estimated 25.0% of the total global market in 2013 and will continue to grow stronger in 2015. Currently, the injectable drug delivery system segment leads the cancer drug delivery market; however, nanoparticles (including micro-needles, patches, and orals) are expected to lead the market in the future.

RESEARCH: INFOGRAPHIC

This infographic presents a brief overview of the research, and highlights the key topics discussed in it.
Click image to view it in full size

Table of Contents

Key Findings

Key Findings (continued)

Key Findings—Options in the Oncology Drug Delivery Market

Scope and Segmentation

Key Questions This Study Will Answer

Market Engineering Measurements

CEO’s Perspective

Key Technologies to Watch

3 Key Predictions

Market Background

Market Segmentation

Total Oncology Drug Delivery Market—Segmentation by Type of Delivery

Total Oncology Drug Delivery Market—Segmentation by Type of Delivery (continued)

Total Oncology Drug Delivery Market—Segmentation by Region

Total Oncology Drug Delivery Market—Segmentation by Top 5 Competitors

Cancer Pain Management Market

New Market Opportunities

Pipeline of Products in Oncology Drug Delivery Market

Attractiveness in Oncology Drug Delivery Market

Market Drivers

Drivers Explained

Drivers Explained (continued)

Market Restraints

Restraints Explained

Market Engineering Measurements

Forecast Assumptions

Revenue Forecast

Revenue Forecast by Segment

Revenue Forecast Discussion

Oral or Injectable Drug Delivery Systems—New Options for Payors

Oral or Injectable Drug Delivery Systems—New Options for Payors (continued)

Oral or Injectable Drug Delivery Systems—New Options for Payors (continued)

Oral or Injectable Drug Delivery Systems—New Options for Payors (continued)

Porter’s 5 Force Analysis

Market Engineering Measurements

Injectable Drug Delivery System Segment—Revenue Forecast

Revenue Forecast Discussion

Injectable Drug Delivery System Segment—Competitive Assessment

Market Engineering Measurements

Oral Drug Delivery System Segment

Revenue Forecast Discussion

Oral Oncolytic—Past, Present, and Future Options

Oral Drug Delivery System Segment—Competitive Assessment

US Market—Overview of Oncology Drug Delivery Market

US Oncology Drug Delivery Market—Revenue Forecast

Europe Market—Overview of Cancer Drug Delivery System

Europe Oncology Drug Delivery Market—Revenue Forecast

RoW Oncology Drug Delivery Market—Overview of Cancer Drug Delivery System

RoW Oncology Drug Delivery Market—Revenue Forecast

Nano Drug Delivery—Future of Cancer Drug Delivery Systems

Currently Marketed Nano Drug Delivery Systems—All Injectable Drug Delivery Systems

Nano Drug Delivery System—Segmentation

Attractive Nano Drug Delivery Systems

Key Nano Drug Delivery Systems—High Potential and Equally Attractive Technology for Future

Intra-nasal Drug Delivery—Next Option in Cancer Pain

Becton, Dickinson and Company (BD)

Evotec AG

Juno Therapeutics, Inc.

West Pharmaceuticals

NEONC Technologies Inc. (NTI)

Future of Cancer Drugs—Drugs in Cases where Tumour will no Longer Respond to Standard Therapy

Conclusions

Frost & Sullivan Awards

Legal Disclaimer

Market Engineering Methodology

Learn More—Next Steps

Related Research
The global oncology drug delivery market (or oncolytics market) was worth $91.00 billion in 2013 and has been growing at an annual rate of 5.0%. The market, which includes drug delivery systems for cancer therapy and cancer pain, is expected to generate $100.96 billion in 2015. The oral drug delivery systems segment accounted for an estimated 25.0% of the total global market in 2013 and will continue to grow stronger in 2015. Currently, the injectable drug delivery system segment leads the cancer drug delivery market; however, nanoparticles (including micro-needles, patches, and orals) are expected to lead the market in the future.
More Information
No Index No
Podcast No
Author Siddharth Dutta
WIP Number P874-01-00-00-00
Is Prebook No